AsiaNet-Pakistan Premier Editorial Content and Press Release Distribution Service
Islamabad, Citi Pharma Ltd. (CPHL) announced moderate growth amidst market volatility at the Pakistan Stock Exchange (PSE). With a daily weighted average rate of Rs. 2,284.61, the pharmaceutical company continues to navigate through challenging market conditions. CPHL, listed since 2021, reported an EPS of Rs. 2.88 for the year 2022/2023, reflecting its steady performance in the sector. The company, with a paid-up capital of Rs. 27.26 million, did not declare any distributions for the year ending June. Despite market fluctuations, Citi Pharma remains resilient, with a book closure on October 20th and a market lot of 10 shares.
Check Also
Atlas Battery Reports Loss of Share Certificates
Karachi: Atlas Battery Limited has reported a loss of share certificates belonging to a late shareholder, Mr. Asrar Ahmed Kazi, with specific details concerning the number and series of the shares lost. This incident, reported on October 7, 2024, invo...
The post Atlas Battery Reports Loss of Share Certificates appeared first on .